AAN 2023

Understanding the global burden of dementia: challenges and opportunities

Impact of the COVID-19 pandemic on patients with dementia and PD and their caregivers in Peru

A novel cognitive assessment based on augmented reality and machine learning

The Women’s Brain Project call to action for an inclusive research agenda in brain health

Digital biomarkers to revolutionize clinical trial conduction in Alzheimer’s disease

NE3107 properties and mode of action

Ongoing concerns regarding lecanemab: efficacy & adverse events

Phase II study of NE3107 in degenerative dementias

The future of focused ultrasound in AD

Blood-based biomarkers for AD diagnosis

Use of DBS to treat Alzheimer’s disease

Updates on anti-amyloid monoclonal antibodies for AD in Phase III trials

Use of AD blood-based biomarkers for trial enrolment

Expanding research into biomarkers for RPD differentiation

PMN310 anti-amyloid antibody preserves learning and memory in animal models